Ruxolitinib
Products in Health Canada’s databases that list Ruxolitinib as a medicinal or active ingredient. Its salts and forms that the databases name on their own have their own pages.
Also listed as “Ruxolitinib (Ruxolitinib Phosphate)” (5). How names are joined
- Drug products
- 5
- 5 authorized now
- Natural health products
- 0
- 0 active licences
- Notices of Compliance
- 5
- Products in all
- 5
Drug products
Authorized products first.
| Name | DIN | Status | Holder | Status since |
|---|---|---|---|---|
| JAKAVI (5 MG) | 02388006 | Marketed | Novartis Pharmaceuticals Canada Inc. | |
| JAKAVI (15 MG) | 02388014 | Marketed | Novartis Pharmaceuticals Canada Inc. | |
| JAKAVI (20 MG) | 02388022 | Marketed | Novartis Pharmaceuticals Canada Inc. | |
| JAKAVI (10 MG) | 02434814 | Marketed | Novartis Pharmaceuticals Canada Inc. | |
| OPZELURA (1.5 %) | 02552434 | Marketed | Incyte Corporation |
Notices of Compliance
Approvals of drug submissions that list it, newest first.